AllianceR&D
Successful Breeding of Euglena utilizing CRISPR-Cas3, a Novel Genome Editing Technology
C4U Corporation and Euglena Co., Ltd. have been conducting collaborative research on the application of CRISPR-Cas3, a novel genome editing technology, in the microalga Euglena since May 2023.
As a result of this research, we are pleased to announce that we have succeeded in genome editing of Euglena utilizing the CRISPR-Cas3 method.
This breakthrough will accelerate the deployment of genome-edited strains of Euglena for industrial applications.
For further details on the research results, please visit the following URL (Japanese only).